3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 1/2
1
Status
Unknown
2
Not yet recruiting
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urinary Bladder Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
HER2-positive Gastric Cancer
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Gastric Adenocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
8
Cystectomy
6
Cisplatin
5
Mitomycin
3
toripalimab
2
tislelizumab
2
disitamab vedotin
2
Radiotherapy
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
zimberelimab
1
trilaciclib
1
sacituzumab govitecan
1
nimotuzumab
1
entinostat
1
durvalumab
1
cemiplimab
1
Transurethral Resection of Bladder
1
Therapeutics
1
Synapsins
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
RC48 antibody
1
Olive Oil
1
Niacinamide
1
Niacin
1
Music Therapy
1
Liquid Biopsy
1
Immunonutrition Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Urinary Bladder Neoplasms
×
disitamab vedotin
×
Clear all
NCT07608224
2026-05-27
HOPE-07-MIBC
West China Hospital
Phase 2/3
Not yet recruiting
240 enrolled
NCT06957561
2025-05-04
DIVON
Sun Yat-sen University
Phase 1/2
Not yet recruiting
30 enrolled